We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Detection of Pathogenic Microorganisms in Semen by Sequencing Sperm RNA

By LabMedica International staff writers
Posted on 11 Feb 2020
Print article
Image:  Human sperm stained for semen quality testing in the clinical laboratory (Photo courtesy of Wikimedia Commons)
Image: Human sperm stained for semen quality testing in the clinical laboratory (Photo courtesy of Wikimedia Commons)
Advanced sequencing of sperm RNA was used to detect genetic material from microorganisms that were present as contaminants in the associated semen.

The current approach for analysis of the male reproductive tract microbiome relies on identification of micoroorganisms grown from cultures. This approach is of limited value, since the majority of pathogens cannot be cultured.

Investigators at Wayne State University (Detroit, MI, USA) and colleagues at the CReATe Fertility Center (Toronto, Canada) and the University of Massachusetts Amherst (USA) conducted a study designed to assess the capacity of human sperm RNA-seq (RNA sequencing) data to gauge the diversity of the microbiome present within the semen.

For this study, the investigators collected 85 semen samples, isolated the sperm RNA, and analyzed the material using RNA sequencing technology. Microbial composition was determined by aligning sequencing reads not mapped to the human genome to the [U.S.] National Center for Biotechnology Information (NCBI) RefSeq bacterial, viral, and archaeal genomes.

Microbial composition within each sample was characterized as a function of microbial associated RNAs. Results revealed that bacteria known to be associated with the male reproductive tract were present at similar levels in all samples representing 11 genera from four phyla with one exception, an outlier. The outlier sample exhibited a dramatic increase in Streptococcus, represented by two operational taxonomic units, S. agalactiae and S. dysgalactiae. These bacteria cause neonatal infection during pregnancy and post-delivery and are linked to significant mortality rates in premature births.

"We show that non-targeted sequencing of human sperm RNA has the potential to provide a profile of micro-organisms (bacteria, viruses, archaea)," said Dr. Stephen Krawetz, professor of fetal therapy and diagnosis at Wayne State University. "This information was recovered from the data typically cast aside as part of routine nucleic acid sequencing. The enhanced sensitivity and specificity of the sequencing technology as compared to current approaches may prove useful as a diagnostic tool for microbial status as part of the routine assessment as we move toward personalized care. Given the recent increase and severity of Streptococcus (agalactiae) infection, as well as others in adults, neonates, and newborns, non-targeted human sperm RNA sequencing data may, in addition to providing fertility status, prove useful as a diagnostic for microbial status."

The RNA sequencing study was published in the January 4, 2020, online edition of the Journal of Assisted Reproduction and Genetics.

Related Links:
Wayne State University
CReATe Fertility Center
University of Massachusetts Amherst


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.